Latest News

2019 +
- September 2019 (4 entries)
- July 2019 (1 entry)
- June 2019 (3 entries)
- May 2019 (4 entries)
- April 2019 (3 entries)
- March 2019 (7 entries)
- February 2019 (2 entries)
- January 2019 (3 entries)
2018 +
- December 2018 (6 entries)
- November 2018 (3 entries)
- October 2018 (4 entries)
- September 2018 (4 entries)
- August 2018 (5 entries)
- June 2018 (3 entries)
- May 2018 (2 entries)
- April 2018 (4 entries)
- March 2018 (6 entries)
- February 2018 (3 entries)
- January 2018 (2 entries)
2017 +
- December 2017 (3 entries)
- November 2017 (5 entries)
- October 2017 (2 entries)
- September 2017 (3 entries)
- July 2017 (4 entries)
- June 2017 (2 entries)
- May 2017 (3 entries)
- April 2017 (5 entries)
- March 2017 (3 entries)
- February 2017 (3 entries)
- January 2017 (3 entries)
2016 +
- November 2016 (1 entry)
- October 2016 (3 entries)
- September 2016 (2 entries)
- July 2016 (1 entry)
- June 2016 (2 entries)
- May 2016 (1 entry)
- April 2016 (2 entries)
- March 2016 (2 entries)
2015 +
- December 2015 (2 entries)
- October 2015 (1 entry)
- September 2015 (2 entries)
- July 2015 (2 entries)
- May 2015 (2 entries)
- April 2015 (1 entry)
- March 2015 (1 entry)
- February 2015 (1 entry)
2014 +
- November 2014 (1 entry)
- October 2014 (3 entries)
- September 2014 (1 entry)
- June 2014 (1 entry)
- March 2014 (1 entry)
2013 +
- November 2013 (1 entry)
- October 2013 (2 entries)
- September 2013 (1 entry)
- August 2013 (3 entries)
- May 2013 (1 entry)
- March 2013 (2 entries)
- February 2013 (3 entries)
- January 2013 (1 entry)
2012 +
- November 2012 (1 entry)
- June 2012 (3 entries)
- May 2012 (1 entry)
- April 2012 (1 entry)

In February, the German Atrial Fibrillation Network (AFNET) enrolled the first patients in the AXAFA – AFNET 5 trial. The trial is designed to test whether novel oral anticoagulants (NOACs) are also suitable for stroke prevention in atrial fibrillation patients undergoing...